Patent details
LUC00312 Product Name: Trémélimumab
Basic Information
- Publication number:
- LUC00312
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP131550915
- Legal Status:
- Active
- Application number:
- LUC00312
- First applicant's nationality:
- Procedural language:
- French
Paediatric Extension
- SPC Extension Filing Date:
- 18/04/2024
- SPC Extension Agent Name:
- ARONOVA S.A.
- SPC Extension Status:
- Granted
- SPC Extension Grant Date:
- 04/08/2025
- SPC Extension Rejection Date:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/22/1712
- Marketing Authorization Type:
- Marketing Authorization Date:
- 21/02/2023
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 01/08/2023
- First Marketing Authorization date:
- 21/02/2023
- Grant date:
- 03/02/2025
- Activation date:
- 02/03/2026
- Publication date:
- 03/08/2023
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 02/03/2031
- SPC Extension Expiration:
- 02/09/2031
- Rejection date:
- Withdrawal date:
Owner
- From:
- 01/08/2023
- Name:
- Pfizer Products Inc.
- Address:
- Eastern Point Road, Groton, CT 06340, United States (US)
Agent
- Name:
- ARONOVA S.A.
- From:
- 01/08/2023
- Address:
- PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2023/10
- Publication date:
- 04/09/2023
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPCX1
- Bulletin edition number:
- 2024/06
- Publication date:
- 06/05/2024
- Description:
- Section G : Applications for extensions for pediatric use – I1E publication
3
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2025/04
- Publication date:
- 04/03/2025
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
4
- Bulletin Heading:
- SPCX2
- Bulletin edition number:
- 2025/10
- Publication date:
- 05/09/2025
- Description:
- Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication
Annual Fees
- Annual Fee Due Date:
- 31/03/2027
- Annual Fee Number:
- 22
- Annual Fee Amount:
- 420 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 18/12/2025
- Last Annual Fee Paid Number:
- 21
- Last Annual Fee Paid Amount:
- 410 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)
| Filing date | Document type | Number of pages |
|---|---|---|
| 04/08/2025 | Outgoing Correspondence | 1 |
| 07/08/2025 | Publication | 1 |
| 07/08/2025 | Certificate | 1 |
| 03/02/2025 | Publication | 1 |
| 03/02/2025 | Certificate | 1 |
| 03/02/2025 | Outgoing Correspondence | 1 |
| 18/04/2024 | Summary of the product caracteristics | 53 |
| 18/04/2024 | General Document | 1 |
| 18/04/2024 | Application Form | 4 |
| 18/04/2024 | Paediatric investigation plan | 1 |
| 18/04/2024 | Marketing authorization | 3 |
| 18/04/2024 | Marketing authorization | 3 |
| 18/04/2024 | MA publication | 9 |
| 18/04/2024 | FNET_DC_FRONTPAGE | 1 |
| 18/04/2024 | Publication | 1 |
| 18/04/2024 | Outgoing Correspondence | 1 |
| 01/08/2023 | Summary of the product caracteristics | 44 |
| 03/08/2023 | Publication | 1 |
| 01/08/2023 | Application Form | 4 |
| 01/08/2023 | General Document | 1 |
| 01/08/2023 | General Document | 1 |
| 01/08/2023 | Marketing authorization | 3 |
| 01/08/2023 | Marketing authorization | 3 |
| 01/08/2023 | MA publication | 8 |
| 03/08/2023 | Outgoing Correspondence | 1 |